Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Sanson

Showing results (261-270 of 290) with videos related to

Pageof 29
Sort By:
Neuro-Oncology|October 21, 2021
Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG)Matthias Preusser, Antonio Silvani, Emilie Le Rhun, et al.
Scientific Reports|May 24, 2019
Publisher Correction: Mendelian randomisation study of the relationship between vitamin D and risk of gliomaHannah Takahashi, Alex J Cornish, Amit Sud, et al.
Cancer Cell|March 10, 2023
Transcriptome analysis reveals tumor microenvironment changes in glioblastomaYouri Hoogstrate, Kaspar Draaisma, Santoesha A Ghisai, et al.
British Journal of Cancer|March 14, 2018
Influence of obesity-related risk factors in the aetiology of gliomaLinden Disney-Hogg, Amit Sud, Philip J Law, et al.
Nature Genetics|July 7, 2009
Genome-wide association study identifies five susceptibility loci for gliomaSanjay Shete, Fay J Hosking, Lindsay B Robertson, et al.
Human Molecular Genetics|February 13, 2013
Deciphering the 8q24.21 association for gliomaVictor Enciso-Mora, Fay J Hosking, Ben Kinnersley, et al.
BMC Medicine|March 16, 2018
Impact of atopy on risk of glioma: a Mendelian randomisation studyLinden Disney-Hogg, Alex J Cornish, Amit Sud, et al.
Nature Cancer|August 19, 2025
Evolutionary trajectories of IDH-mutant astrocytoma identify molecular grading markers related to cell cyclingWies R Vallentgoed, Youri Hoogstrate, Karin A van Garderen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2024
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 OligodendrogliomaSalah Eddine O Kacimi, Caroline Dehais, Loïc Feuvret, et al.
Trends in Cancer|March 30, 2023
Challenges in glioblastoma research: focus on the tumor microenvironment: (Trends in Cancer, 9:1 p:9-27, 2023)Andreas Bikfalvi, Cristine Alves da Costa, Tony Avril, et al.
Pageof 29

Showing results (261-270 of 290) with videos related to

Sort By:
Pageof 29
Neuro-Oncology|October 21, 2021
Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG)Matthias Preusser, Antonio Silvani, Emilie Le Rhun, et al.
Scientific Reports|May 24, 2019
Publisher Correction: Mendelian randomisation study of the relationship between vitamin D and risk of gliomaHannah Takahashi, Alex J Cornish, Amit Sud, et al.
Cancer Cell|March 10, 2023
Transcriptome analysis reveals tumor microenvironment changes in glioblastomaYouri Hoogstrate, Kaspar Draaisma, Santoesha A Ghisai, et al.
British Journal of Cancer|March 14, 2018
Influence of obesity-related risk factors in the aetiology of gliomaLinden Disney-Hogg, Amit Sud, Philip J Law, et al.
Nature Genetics|July 7, 2009
Genome-wide association study identifies five susceptibility loci for gliomaSanjay Shete, Fay J Hosking, Lindsay B Robertson, et al.
Human Molecular Genetics|February 13, 2013
Deciphering the 8q24.21 association for gliomaVictor Enciso-Mora, Fay J Hosking, Ben Kinnersley, et al.
BMC Medicine|March 16, 2018
Impact of atopy on risk of glioma: a Mendelian randomisation studyLinden Disney-Hogg, Alex J Cornish, Amit Sud, et al.
Nature Cancer|August 19, 2025
Evolutionary trajectories of IDH-mutant astrocytoma identify molecular grading markers related to cell cyclingWies R Vallentgoed, Youri Hoogstrate, Karin A van Garderen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2024
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 OligodendrogliomaSalah Eddine O Kacimi, Caroline Dehais, Loïc Feuvret, et al.
Trends in Cancer|March 30, 2023
Challenges in glioblastoma research: focus on the tumor microenvironment: (Trends in Cancer, 9:1 p:9-27, 2023)Andreas Bikfalvi, Cristine Alves da Costa, Tony Avril, et al.
Pageof 29